Establishment Labs Holdings (ESTA) Long-Term Debt Issuances (2017 - 2024)
Establishment Labs Holdings' quarterly Long-Term Debt Issuances came in at $24.5 million in Q4 2024, little changed quarter-over-quarter from $24.5 million in Q4 2022.
Establishment Labs Holdings has reported Long-Term Debt Issuances for 3 years, with the latest figure at $24.5 million in Q4 2024.
- For the quarter ending Q4 2024, Long-Term Debt Issuances changed N/A year-over-year to $24.5 million; the trailing twelve-month figure through Dec 2025 stood at $24.5 million (down 50.03% YoY), and the FY2025 full-year result was $24.5 million, changed 0.13% from the prior year.
- Long-Term Debt Issuances for Q4 2024 stood at $24.5 million, roughly flat from $24.5 million in the prior quarter.
- The five-year high for Long-Term Debt Issuances was $24.5 million in Q4 2022, with the low at $24.5 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 19.86 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 11.71 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 1.15 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Establishment Labs Holdings | 2.04 Bn | 1.97 Bn | 42.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 24.47 Mn |
| Dec 31, 2024 | 24.47 Mn |
| Dec 31, 2022 | 24.50 Mn |
| Dec 31, 2022 | 24.50 Mn |
| Dec 31, 2017 | -27.65 Mn |
| Dec 31, 2017 | -27.65 Mn |
| Sep 30, 2017 | 27.65 Mn |
| Sep 30, 2017 | 27.65 Mn |